Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Transparency Market Research | PRODUCT CODE: 1046466

Cover Image

PUBLISHER: Transparency Market Research | PRODUCT CODE: 1046466

HER2 Breast Cancer Test Market (Test Type: Immunohistochemistry and Fluorescence/Chromogenic In Situ Hybridization ; and End-user: Hospitals and Diagnostic Laboratories) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

PUBLISHED:
PAGES: 121 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 5795
PDF (Multi-user License)
USD 8795
PDF (Corporate License)
USD 11795

Add to Cart

Tablet Hardness Testers Market - Scope of Report

TMR's report on the global tablet hardness testers market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2031. The report provides revenue of the global tablet hardness testers market for the period from 2017 to 2031, considering 2020 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global tablet hardness testers market from 2021 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the tablet hardness testers market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global tablet hardness testers market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global tablet hardness testers market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global tablet hardness testers market.

The report delves into the competitive landscape of the global tablet hardness testers market. Key players operating in the global tablet hardness testers market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global tablet hardness testers market profiled in this report.

Key Questions Answered in Tablet Hardness Testers Market Report

What is the sales/revenue generated by tablet hardness testers across all regions during the forecast period?

What are the opportunities in the global tablet hardness testers market?

What are the major drivers, restraints, opportunities, and threats in the market?

Which regional market is set to expand at the fastest CAGR during the forecast period?

Which segment is expected to generate the highest revenue globally in 2031?

Which segment is projected to expand at the highest CAGR during the forecast period?

What are the market positions of different companies operating in the global market?

Tablet Hardness Testers Market - Research Objectives and Research Approach

The comprehensive report on the global tablet hardness testers market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global tablet hardness testers market in terms of product type, function, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global tablet hardness testers market.

Product Code: TMRGL83844

Table of Contents

1. Preface

  • 1.1. Report Scope and Market Segmentation
  • 1.2. Research Highlights

2. Assumptions and Research Methodology

  • 2.1. Assumptions and Acronyms Used
  • 2.2. Research Methodology

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Global HER2 Breast Cancer Test Market Forecast
  • 4.3. Global HER2 Breast Cancer Test Market Outlook
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunity

5. Key Insights

  • 5.1. Revenue Model
  • 5.2. Pricing Analysis
  • 5.3. COVID-19 Impact Analysis

6. Global HER2 Breast Cancer Test Market Analysis, by Test Type

  • 6.1. Introduction
  • 6.2. Global HER2 Breast Cancer Test Market Value Share Analysis, by Test Type
  • 6.3. Global HER2 Breast Cancer Test Market Forecast, by Test Type
    • 6.3.1. Immunohistochemistry (IHC)
    • 6.3.2. Fluorescence/Chromogenic In Situ Hybridization (FISH/CISH)
  • 6.4. Global HER2 Breast Cancer Test Market Analysis, by Test Type
  • 6.5. Global HER2 Breast Cancer Test Market Attractiveness Analysis, by Test Type

7. Global HER2 Breast Cancer Test Market Analysis, by End-user

  • 7.1. Introduction
  • 7.2. Global HER2 Breast Cancer Test Market Value Share Analysis, by End-user
  • 7.3. Global HER2 Breast Cancer Test Market Forecast, by End-user
    • 7.3.1. Hospitals
    • 7.3.2. Diagnostic Laboratories
  • 7.4. Global HER2 Breast Cancer Test Market Analysis, by End-user
  • 7.5. Global HER2 Breast Cancer Test Market Attractiveness Analysis, by End-user

8. Global HER2 Breast Cancer Test Market Analysis, by Region

  • 8.1. Introduction
  • 8.2. Global HER2 Breast Cancer Test Market Value Share Analysis, by Region
  • 8.3. Global HER2 Breast Cancer Test Market Forecast, by Region
    • 8.3.1. North America
    • 8.3.2. Europe
    • 8.3.3. Asia Pacific
    • 8.3.4. Latin America
    • 8.3.5. Middle East & Africa

9. North America HER2 Breast Cancer Test Market Analysis

  • 9.1. North America HER2 Breast Cancer Test Market Overview
  • 9.2. North America HER2 Breast Cancer Test Market Value Share and Attractiveness Analysis, by Country
    • 9.2.1. U.S.
    • 9.2.2. Canada
  • 9.3. North America HER2 Breast Cancer Test Market Value Share and Attractiveness analysis, by Test Type
  • 9.4. North America HER2 Breast Cancer Test Market Forecast, by Test Type
    • 9.4.1. Immunohistochemistry (IHC)
    • 9.4.2. Fluorescence/Chromogenic In Situ Hybridization (FISH/CISH)
  • 9.5. North America HER2 Breast Cancer Test Market Value Share and Attractiveness Analysis, by End-user
  • 9.6. North America HER2 Breast Cancer Test Market Forecast, by End-user
    • 9.6.1. Hospitals
    • 9.6.2. Diagnostic Laboratories

10. Europe HER2 Breast Cancer Test Market Analysis

  • 10.1. Europe HER2 Breast Cancer Test Market Overview
  • 10.2. Europe HER2 Breast Cancer Test Market Value Share and Attractiveness analysis, by Country/Sub-region
    • 10.2.1. Germany
    • 10.2.2. U.K.
    • 10.2.3. France
    • 10.2.4. Italy
    • 10.2.5. Spain
    • 10.2.6. Rest of Europe
  • 10.3. Europe HER2 Breast Cancer Test Market Value Share and Attractiveness Analysis, by Test Type
  • 10.4. Europe HER2 Breast Cancer Test Market Forecast, by Test Type
    • 10.4.1. Immunohistochemistry (IHC)
    • 10.4.2. Fluorescence/Chromogenic In Situ Hybridization (FISH/CISH)
  • 10.5. Europe HER2 Breast Cancer Test Market Value Share and Attractiveness Analysis, by End-user
  • 10.6. Europe HER2 Breast Cancer Test Market Forecast, by End-user
    • 10.6.1. Hospitals
    • 10.6.2. Diagnostic Laboratories

11. Asia Pacific HER2 Breast Cancer Test Market Analysis

  • 11.1. Asia Pacific HER2 Breast Cancer Test Market Overview
  • 11.2. Asia Pacific HER2 Breast Cancer Test Market Value Share and Attractiveness Analysis, by Country/Sub-region
    • 11.2.1. China
    • 11.2.2. Japan
    • 11.2.3. India
    • 11.2.4. Australia & New Zealand
    • 11.2.5. Rest of Asia Pacific
  • 11.3. Asia Pacific HER2 Breast Cancer Test Market Value Share and Attractiveness analysis, by Test Type
  • 11.4. Asia Pacific HER2 Breast Cancer Test Market Forecast, by Test Type
    • 11.4.1. Immunohistochemistry (IHC)
    • 11.4.2. Fluorescence/Chromogenic In Situ Hybridization (FISH/CISH)
  • 11.5. Asia Pacific HER2 Breast Cancer Test Market Value Share and Attractiveness analysis, by End-user
  • 11.6. Asia Pacific HER2 Breast Cancer Test Market Forecast, by End-user
    • 11.6.1. Hospitals
    • 11.6.2. Diagnostic Laboratories

12. Latin America HER2 Breast Cancer Test Market Analysis

  • 12.1. Latin America HER2 Breast Cancer Test Market Overview
  • 12.2. Latin America HER2 Breast Cancer Test Market Value Share and Attractiveness analysis, by Country/Sub-region
    • 12.2.1. Brazil
    • 12.2.2. Mexico
    • 12.2.3. Rest of Latin America
  • 12.3. Latin America HER2 Breast Cancer Test Market Value Share and Attractiveness analysis, by Test Type
  • 12.4. Latin America HER2 Breast Cancer Test Market Forecast, by Test Type
    • 12.4.1. Immunohistochemistry (IHC)
    • 12.4.2. Fluorescence/Chromogenic In Situ Hybridization (FISH/CISH)
  • 12.5. Latin America HER2 Breast Cancer Test Market Value Share and Attractiveness analysis, by End-user
  • 12.6. Latin America HER2 Breast Cancer Test Market Forecast, by End-user
    • 12.6.1. Hospitals
    • 12.6.2. Diagnostic Laboratories

13. Middle East & Africa HER2 Breast Cancer Test Market Analysis

  • 13.1. Middle East & Africa HER2 Breast Cancer Test Market Overview
  • 13.2. Middle East & Africa HER2 Breast Cancer Test Market Value Share and Attractiveness Analysis, by Country/Sub-region
    • 13.2.1. GCC Countries
    • 13.2.2. South Africa
    • 13.2.3. Rest of Middle East & Africa
  • 13.3. Middle East & Africa HER2 Breast Cancer Test Market Value Share and Attractiveness Analysis, by Test Type
  • 13.4. Middle East & Africa HER2 Breast Cancer Test Market Forecast, by Test Type
    • 13.4.1. Immunohistochemistry (IHC)
    • 13.4.2. Fluorescence/Chromogenic In Situ Hybridization (FISH/CISH)
  • 13.5. Middle East & Africa HER2 Breast Cancer Test Market Value Share and Attractiveness Analysis, by End-user
  • 13.6. Middle East & Africa HER2 Breast Cancer Test Market Forecast, by End-user
    • 13.6.1. Hospitals

14. Competition Landscape

  • 14.1. Market Player - Competition Matrix (by tier and size of companies)
  • 14.2. Market Share Analysis, by Company, 2019
  • 14.3. Company Profiles
    • 14.3.1. Abbott Laboratories
      • 14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.1.2. Product Portfolio
      • 14.3.1.3. SWOT Analysis
      • 14.3.1.4. Strategic Overview
    • 14.3.2. BioGenex
      • 14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.2.2. Product Portfolio
      • 14.3.2.3. SWOT Analysis
      • 14.3.2.4. Strategic Overview
    • 14.3.3. Agilent Technologies, Inc.
      • 14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.3.2. Product Portfolio
      • 14.3.3.3. SWOT Analysis
      • 14.3.3.4. Strategic Overview
    • 14.3.4. Leica Biosystems
      • 14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.4.2. Product Portfolio
      • 14.3.4.3. SWOT Analysis
      • 14.3.4.4. Strategic Overview
    • 14.3.5. Roche
      • 14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.5.2. Product Portfolio
      • 14.3.5.3. SWOT Analysis
      • 14.3.5.4. Strategic Overview
    • 14.3.6. Mylab Discovery Solutions Pvt. Ltd.
      • 14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.6.2. Product Portfolio
      • 14.3.6.3. SWOT Analysis
      • 14.3.6.4. Strategic Overview
Product Code: TMRGL83844

List of Tables

  • Table 01: Global HER2 Breast Cancer Test Market Size (US$ Mn) Forecast, by Test Type, 2017-2031
  • Table 02: Global HER2 Breast Cancer Test Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Table 03: North America HER2 Breast Cancer Test Market Revenue (US$ Mn) Forecast, by Country, 2017-2031
  • Table 04: North America HER2 Breast Cancer Test Market Size (US$ Mn) Forecast, by Test Type, 2017-2031
  • Table 05: North America HER2 Breast Cancer Test Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 06: Europe HER2 Breast Cancer Test Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 07: Europe HER2 Breast Cancer Test Market Size (US$ Mn) Forecast, by Test Type, 2017-2031
  • Table 08: Europe HER2 Breast Cancer Test Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 09: Asia Pacific HER2 Breast Cancer Test Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 10: Asia Pacific HER2 Breast Cancer Test Market Size (US$ Mn) Forecast, by Test Type, 2017-2031
  • Table 11: Asia Pacific HER2 Breast Cancer Test Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 12: Latin America HER2 Breast Cancer Test Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 13: Latin America HER2 Breast Cancer Test Market Size (US$ Mn) Forecast, by Test Type, 2017-2031
  • Table 14: Latin America HER2 Breast Cancer Test Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 15: Middle East & Africa HER2 Breast Cancer Test Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 16: Middle East & Africa HER2 Breast Cancer Test Market Size (US$ Mn) Forecast, by Test Type, 2017-2031
  • Table 17: Middle East & Africa HER2 Breast Cancer Test Market Size (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

  • Figure 01: Global HER2 Breast Cancer Test Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 02: Global HER2 Breast Cancer Test Market Value Share, by Test Type (2020)
  • Figure 03: Global HER2 Breast Cancer Test Market Value Share, by End-user (2020)
  • Figure 04: Global HER2 Breast Cancer Test Market Value Share, by Region (2020)
  • Figure 05: Global HER2 Breast Cancer Test Market Value Share Analysis, by Test Type, 2020 and 2031
  • Figure 06: Global HER2 Breast Cancer Test Market Revenue (US$ Mn), by Immunohistochemistry (IHC), 2017-2031
  • Figure 07: Global HER2 Breast Cancer Test Market Revenue (US$ Mn), by Fluorescence/Chromogenic In Situ Hybridization (FISH/CISH), 2017-2031
  • Figure 08: Global HER2 Breast Cancer Test Market Attractiveness Analysis, by Test Type, 2021-2031
  • Figure 09: Global HER2 Breast Cancer Test Market Value Share Analysis, by Region, 2020 and 2031
  • Figure 10: Global HER2 Breast Cancer Test Market Attractiveness, by Region, 2021-2031
  • Figure 11: North America HER2 Breast Cancer Test Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 12: North America HER2 Breast Cancer Test Market Value Share (%), by Country, 2020 and 2031
  • Figure 13: North America HER2 Breast Cancer Test Market Attractiveness, by Country, 2021-2031
  • Figure 14: North America HER2 Breast Cancer Test Market Value Share Analysis, by Test Type, 2020 and 2031
  • Figure 15: North America HER2 Breast Cancer Test Market Attractiveness, by Test Type, 2021-2031
  • Figure 16: North America HER2 Breast Cancer Test Market Value Share Analysis, by End-user, 2020 and 2031
  • Figure 17: North America HER2 Breast Cancer Test Market Attractiveness, by End-user, 2021-2031
  • Figure 18: Europe HER2 Breast Cancer Test Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 19: Europe HER2 Breast Cancer Test Market Value Share (%), by Country/Sub-region, 2020 and 2031
  • Figure 20: Europe HER2 Breast Cancer Test Market Attractiveness, by Country/Sub-region, 2021-2031
  • Figure 21: Europe HER2 Breast Cancer Test Market Value Share Analysis, by Test Type, 2020 and 2031
  • Figure 22 Europe HER2 Breast Cancer Test Market Attractiveness, by Test Type, 2021-2031
  • Figure 23: Europe HER2 Breast Cancer Test Market Value Share Analysis, by End-user, 2020 and 2031
  • Figure 24: Europe HER2 Breast Cancer Test Market Attractiveness, by End-user, 2021-2031
  • Figure 25: Asia Pacific HER2 Breast Cancer Test Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 26: Asia Pacific HER2 Breast Cancer Test Market Value Share (%), by Country/Sub-region, 2020 and 2031
  • Figure 27: Asia Pacific HER2 Breast Cancer Test Market Attractiveness, by Country/Sub-region, 2021-2031
  • Figure 28: Asia Pacific HER2 Breast Cancer Test Market Value Share Analysis, by Test Type, 2020 and 2031
  • Figure 29: Asia Pacific HER2 Breast Cancer Test Market Attractiveness, by Test Type, 2021-2031
  • Figure 30: Asia Pacific HER2 Breast Cancer Test Market Value Share Analysis, by End-user, 2020 and 2031
  • Figure 31: Asia Pacific HER2 Breast Cancer Test Market Attractiveness, by End-user, 2021-2031
  • Figure 32: Latin America HER2 Breast Cancer Test Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 33: Latin America HER2 Breast Cancer Test Market Value Share (%), by Country/Sub-region, 2020 and 2031
  • Figure 34: Latin America HER2 Breast Cancer Test Market Attractiveness, by Country/Sub-region, 2021-2031
  • Figure 35: Latin America HER2 Breast Cancer Test Market Value Share Analysis, by Test Type, 2020 and 2031
  • Figure 36: Latin America HER2 Breast Cancer Test Market Attractiveness, by Test Type, 2021-2031
  • Figure 37: Latin America HER2 Breast Cancer Test Market Value Share Analysis, by End-user, 2020 and 2031
  • Figure 38: Latin America HER2 Breast Cancer Test Market Attractiveness, by End-user, 2021-2031
  • Figure 39: Middle East & Africa HER2 Breast Cancer Test Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 40: Middle East & Africa HER2 Breast Cancer Test Market Value Share (%), by Country/Sub-region, 2020 and 2031
  • Figure 41: Middle East & Africa HER2 Breast Cancer Test Market Attractiveness, by Country/Sub-region, 2021-2031
  • Figure 42: Middle East & Africa HER2 Breast Cancer Test Market Value Share Analysis, by Test Type, 2020 and 2031
  • Figure 43: Middle East & Africa HER2 Breast Cancer Test Market Attractiveness, by Test Type, 2021-2031
  • Figure 44: Middle East & Africa HER2 Breast Cancer Test Market Value Share Analysis, by End-user, 2020 and 2031
  • Figure 45: Middle East & Africa HER2 Breast Cancer Test Market Attractiveness, by End-user, 2021-2031
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!